Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 708

2.

Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial.

Krebs EE, Gravely A, Nugent S, Jensen AC, DeRonne B, Goldsmith ES, Kroenke K, Bair MJ, Noorbaloochi S.

JAMA. 2018 Mar 6;319(9):872-882. doi: 10.1001/jama.2018.0899.

PMID:
29509867
3.

A prospective, randomized, open label, controlled study investigating the efficiency and safety of 3 different methods of rectus sheath block analgesia following midline laparotomy.

Purdy M, Kinnunen M, Kokki M, Anttila M, Eskelinen M, Hautajärvi H, Lehtonen M, Kokki H.

Medicine (Baltimore). 2018 Feb;97(7):e9968. doi: 10.1097/MD.0000000000009968.

4.

Effect of oxycodone hydrochloride combined with flurbiprofen axetil for intravenous patient-controlled analgesia in lower abdominal patients: A randomized trial.

Xiang X, Yuan X, Lian Y, Fang J, Wu Y.

Medicine (Baltimore). 2018 Feb;97(7):e9911. doi: 10.1097/MD.0000000000009911.

6.

Intranasal abuse potential of an abuse-deterrent oxycodone formulation compared to oxycodone immediate release and placebo in nondependent, recreational opioid users.

Setnik B, Schoedel K, Bartlett C, Dick C, Hakim N, Geoffroy P.

J Opioid Manag. 2017 Nov/Dec;13(6):449-464. doi: 10.5055/jom.2017.0421.

PMID:
29308591
7.

Effect of a Single Dose of Oral Opioid and Nonopioid Analgesics on Acute Extremity Pain in the Emergency Department: A Randomized Clinical Trial.

Chang AK, Bijur PE, Esses D, Barnaby DP, Baer J.

JAMA. 2017 Nov 7;318(17):1661-1667. doi: 10.1001/jama.2017.16190.

8.

Patient-reported health-related quality of life, work productivity, and activity impairment during treatment with ALO-02 (extended-release oxycodone and sequestered naltrexone) for moderate-to-severe chronic low back pain.

Weil AJ, Masters ET, Barsdorf AI, Bass A, Pixton G, Wilson JG, Wolfram G.

Health Qual Life Outcomes. 2017 Oct 17;15(1):202. doi: 10.1186/s12955-017-0749-y.

9.

Prolonged-Release Oxycodone/Naloxone Improves Anal Sphincter Relaxation Compared to Oxycodone Plus Macrogol 3350.

Poulsen JL, Brock C, Grønlund D, Liao D, Gregersen H, Krogh K, Drewes AM.

Dig Dis Sci. 2017 Nov;62(11):3156-3166. doi: 10.1007/s10620-017-4784-7. Epub 2017 Oct 6.

PMID:
28986667
10.

Selection of opioids for cancer-related pain using a biomarker: a randomized, multi-institutional, open-label trial (RELIEF study).

Matsuoka H, Tsurutani J, Chiba Y, Fujita Y, Terashima M, Yoshida T, Sakai K, Otake Y, Koyama A, Nishio K, Nakagawa K.

BMC Cancer. 2017 Oct 6;17(1):674. doi: 10.1186/s12885-017-3664-z.

11.

Transumbilical versus lateral transabdominal removal of benign adnexal masses in laparoscopic surgery-A randomized trial.

Kilpiö O, Härkki PSM, Mentula MJ, Jokela RM, Pakarinen PI.

Eur J Obstet Gynecol Reprod Biol. 2017 Nov;218:49-54. doi: 10.1016/j.ejogrb.2017.08.040. Epub 2017 Sep 4.

PMID:
28950190
12.

Bioavailability of oxycodone after administration of a new prolonged-release once-daily tablet formulation in healthy subjects, in comparison to an established twice-daily tablet
.

Scheidel B, Maritz MA, Gschwind YJ, Steigerwald K, Guth V, Kovacs P, Rey H.

Int J Clin Pharmacol Ther. 2017 Nov;55(11):881-890. doi: 10.5414/CP203005.

13.

Efficacy and safety of controlled-release oxycodone/naloxone versus controlled-release oxycodone in Korean patients with cancer-related pain: a randomized controlled trial.

Lee KH, Kim TW, Kang JH, Kim JS, Ahn JS, Kim SY, Yun HJ, Eum YJ, Koh SA, Kim MK, Hong YS, Kim JE, Lee GW.

Chin J Cancer. 2017 Sep 11;36(1):74. doi: 10.1186/s40880-017-0241-4.

14.

A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients.

Nosek K, Leppert W, Nosek H, Wordliczek J, Onichimowski D.

Drug Des Devel Ther. 2017 Aug 22;11:2409-2419. doi: 10.2147/DDDT.S141007. eCollection 2017.

15.

Prolonged release oxycodone and naloxone treatment counteracts opioid-induced constipation in patients with severe pain compared to previous analgesic treatment.

Koopmans-Klein G, Van Op den Bosch J, van Megen Y, Prenen H, Huygen F, Mancini I.

Curr Med Res Opin. 2017 Dec;33(12):2217-2227. doi: 10.1080/03007995.2017.1367276. Epub 2017 Sep 11.

PMID:
28805471
16.

Effects of oxycodone on immune function in patients undergoing radical resection of rectal cancer under general anesthesia.

Cui JH, Jiang WW, Liao YJ, Wang QH, Xu M, Li Y.

Medicine (Baltimore). 2017 Aug;96(31):e7519. doi: 10.1097/MD.0000000000007519.

17.

Transcutaneous electrical nerve stimulation for postoperative pain relief after arthroscopic rotator cuff repair: a prospective double-blinded randomized trial.

Mahure SA, Rokito AS, Kwon YW.

J Shoulder Elbow Surg. 2017 Sep;26(9):1508-1513. doi: 10.1016/j.jse.2017.05.030. Epub 2017 Jul 20.

PMID:
28735847
18.

Combatting pain after orthopedic/trauma surgery- perioperative oral extended-release tapentadol vs. extended-release oxycodone/naloxone.

Haeseler G, Schaefers D, Prison N, Ahrens J, Liu X, Karch A.

BMC Anesthesiol. 2017 Jul 11;17(1):91. doi: 10.1186/s12871-017-0383-6.

19.

The analgesic efficacy of oxycodone hydrochloride versus fentanyl during outpatient artificial abortion operation: A randomized trial.

Xie K, Zhang W, Fang W, Lian Y, Lin S, Fang J.

Medicine (Baltimore). 2017 Jun;96(26):e7376. doi: 10.1097/MD.0000000000007376.

20.

The effects of analgesics on central processing of tonic pain: A cross-over placebo controlled study.

Lelic D, Hansen TM, Mark EB, Olesen AE, Drewes AM.

Neuropharmacology. 2017 Sep 1;123:455-464. doi: 10.1016/j.neuropharm.2017.06.022. Epub 2017 Jun 22.

PMID:
28648913

Supplemental Content

Loading ...
Support Center